What is Haemonetics's deferred revenue timing percentage?

Haemonetics (HAE) reported deferred revenue timing percentage of 79% in Q4 2025.

How has Haemonetics's deferred revenue timing percentage changed year-over-year?

Haemonetics's deferred revenue timing percentage increased by 216.0% year-over-year, from 25% to 79%.

Haemonetics HAE Deferred Revenue Timing Percentage

Deferred Revenue Timing Percentage at other companies

DanaherDHR

——

Baxter InternationalBAX

——

FortiveFTV

——

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligationPercentage.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's deferred revenue timing percentage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's deferred revenue timing percentage?: Haemonetics (HAE) reported deferred revenue timing percentage of 79% in Q4 2025.
How has Haemonetics's deferred revenue timing percentage changed year-over-year?: Haemonetics's deferred revenue timing percentage increased by 216.0% year-over-year, from 25% to 79%.